WANTIFO Launches Hair Dryer DualCare with Advanced Plasma Ionic Tech
The WANTIFO Hair Dryer DualCare, boasting a high-speed 110,000 RPM brushless motor and cutting-edge Plasma Ionic Technology, emits 200 million positive and negative ions. This feature not only improves scalp health but also reduces hair loss and curbs frizz, resulting in softer, healthier, and more lustrous hair.
Efficient by design, the WANTIFO Hair Dryer DualCare ensures quick drying without heat damage. It includes customizable temperature settings, three distinct heat and speed options, and an HD LCD for user-friendly operation. Its 360° magnetic nozzle caters to different hair types and lengths, making it a versatile tool for any hair care routine.
Weighing just 0.82 pounds and maintaining a noise level under 60dB, the DualCare is perfect for home and travel use. It's built with safety in mind, featuring a UL-certified US ALCI safety plug, automatic protection mechanisms, and an easy-to-use auto-cleaning function.
Experience the DualCare difference with an exclusive 30% off. Use code "30WANTIFO" at here.
For more information on the DualCare Hair Dryer, please contact:
Marketing Manager:
Email: [email protected]
Official Website: https://wantifo.com/
Amazon Store: https://www.amazon.com/stores/WAINTIFOISWONDERFUL/page/8BB8E322-FBEA-4027-AEE0-CBE5B723D1F0?ref_=ast_bln
Social Medias: https://linktr.ee/wantifo
About WANTIFO
WANTIFO, a dynamic brand in the haircare industry, focuses on efficient, damage-free drying and stylish functionality, revolutionizing daily hair routines.
View original content:https://www.prnewswire.com/news-releases/wantifo-launches-hair-dryer-dualcare-with-advanced-plasma-ionic-tech-302010607.html
SOURCE Wantifo
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- THE BIG GREEK CAFÉ SELECTS WESTVIEW PROMENADE FOR SECOND LOCATION IN FREDERICK COUNTY, MARYLAND
- Boots Group Finco L.P. and The Boots Group Luxco S.à r.l. Announce Expiration and Results of the Consent Solicitation for their €650,000,000 5.375% Senior Secured Notes due 2032 and £375,000,000 7
- Novo's Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older with type 2 diabetes
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share